- Display 30 Products per page
Published: January 5, 2022 | Price: $3,750.00 – $7,500.00
This new Kalorama Information report, World Market for Blood Screening, focuses on the evolving, multibillion dollar global blood screening market. Blood screening is a medical process that scans the blood for infectious diseases or conditions. In developed nations, donated blood is screened for various pathogens. It is a mature market; however, growth comes from new technologies, increased volume and increased testing in developing nations. Blood screening testing’s primary objectives are to monitor the appearance of newly discovered infectious agents in...Published: November 4, 2020 | Price: $4,000.00 – $8,000.00
Vaccine Market Tops 37 Billion, Says Kalorama Information Report In 2020, the global market for preventive vaccines is valued at $37.4 billion, up overall from $30.7 billion in 2015. The finding was made in Kalorama Information's report, Vaccines 2020. Strong continued growth in the global vaccines market is expected through 2025. THE MOST CURRENT VACCINE MARKET INFORMATION The vaccine market is a growth market for the experienced competitors participating in it.Seven billion dollars in new sales have occurred in the past...Published: October 6, 2022 | Price: $5,000.00 – $10,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. This latest report from Kalorama Information, United States Market for In Vitro Diagnostic (IVD) Tests, 4th Edition, discusses the trends shaping the present and future of the IVD...Published: June 7, 2021 | Price: $4,000.00 – $8,000.00
The U.S. market dominates the IVD industry AND remains the core geographical IVD market in the world. Yet this major multi-billion-dollar IVD market is in a state of flux, trying to manage a myriad of issues, all of which collide with a huge system that costs more than any other in the world. COVID-19 had a profound effect on the IVD diagnostic industry – some segments exploded and others languished. At this point in time, it is hard to predict...Published: April 28, 2022 | Price: $6,000.00 – $12,000.00
As discussed in this report, The Worldwide Market for Point-of-Care (POC) Diagnostic Tests, 9th Edition, POC testing has skyrocketed in the last 20 years as demand for accurate and rapid testing has blossomed both inside and outside the hospital setting. An in-depth look at the global POC testing market yielded several interesting facts that are explored in this study. Emerging technological innovations in smartphones, biosensors, lab-on-a-chip and wearable devices are influencing the POC landscape. The driving force behind these innovations...Published: April 23, 2024 | Price: $7,000.00 – $14,000.00
NOW IN ELEVEN EDITIONS—The Worldwide Market for Point-of-Care (POC) Diagnostic Tests forecasts the POC market through 2028. Lab-based analyzers in hospitals and reference labs are the cornerstone of revenues in the in vitro diagnostics (IVD) industry. However, the point-of-care (POC) segment is seen as a key growth area. Point-of-care refers to tests that can provide meaningful results during a provider visit or in the patient's home. Over the past two decades, Kalorama Information has observed that POC tests present significant...Published: April 13, 2023 | Price: $6,000.00 – $12,000.00
The point-of-care diagnostics market has long been the opportunity market within IVD. Kalorama publishes a full-scope market research study annually on point of care (POC) devices that can test near the patient for maximum benefit to healthcare encounters. While tests run on lab-based analyzers, remain the bedrock of IVD revenues, point of care has always been seen as the growth area. There are more companies in the point of care market, and it is a top segment of investment. Now...Published: August 24, 2023 | Price: $8,750.00 – $17,500.00
"The most trusted and essential report on the global IVD industry." For Two Decades, One Volume Has Offered Complete Coverage of the IVD Industry The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic Tests is a must have for anyone interested or involved in the IVD industry. Having a guide for the state of IVD and its future is a vital part of making well-informed decisions. The 16th edition of Kalorama’s Worldwide Market for In Vitro Diagnostic...Published: February 22, 2024 | Price: $5,000.00 – $10,500.00
Vaccines offer long-term or permanent immunity against diseases. They have been a cornerstone of preventive medicine for over 70 years, stimulating an immune response to specific diseases. The widespread adoption of effective vaccines has led to the near-elimination of many deadly diseases, making vaccination one of the greatest public health achievements of the 20th century. Thanks to public vaccination programs, vaccine-preventable diseases and related deaths are now rare in developed nations and decreasing globally. Smallpox has been eradicated, polio eliminated...Published: September 23, 2022 | Price: $5,000.00 – $10,000.00
V A C C I N E M A R K E T E X C E E D S $200 B I L L I O N In 2022, the global market for preventive vaccines is valued at $202.6 billion. That's up from $34.1 billion in 2017, and just $25 billion in 2010. Infectious diseases are some of the deadliest diseases that pose significant risk to human life. Sales increased from $127.6 billion in 2021 to $202.6 billion in...Published: December 19, 2023 | Price: $3,750.00 – $7,500.00
Recent years saw molecular diagnostics emerge as the fastest growing segment within the global in vitro diagnostics (IVD) market. The market was both boosted and challenged in unexpected ways by COVID-19. But where does the multi-billion-dollar molecular diagnostic market stand post pandemic? This new report by Kalorama Information, The World Market for Molecular Diagnostics, 12th Edition, reveals that post-pandemic the market remains ripe with opportunity, notably in the areas of infectious diseases, cancer, and transplant diagnostics. Global demand persists, with...Published: January 23, 2023 | Price: $5,000.00 – $10,000.00
This report, The Market for In Vitro Diagnostic (IVD) Tests in Latin America, focuses on the market for reagents and instruments in the most important countries of the region. Argentina, Brazil, Chile, Colombia, Mexico, Peru and Venezuela are singled out for a deeper level of analysis; the countries of Bolivia, Costa Rica, Cuba, Dominican Republic, Ecuador, El Salvador, Guatemala, Guyana, Haiti, Honduras, Nicaragua, Panama, Paraguay, and Uruguay were also considered to provide a complete overview of the region. Combined, these...Published: March 7, 2024 | Price: $5,000.00 – $10,500.00
Molecular point-of-care (mPOC) diagnostic solutions offer enhanced sensitivity and specificity compared to existing near-patient and rapid tests. They expand diagnostic capabilities in critical care units, physician offices, outpatient clinics, and community health posts, aiming to assess conditions or admit patients accurately. The concept blends the accessibility of point-of-care (POC) testing with the precision of molecular technology. Kalorama Information has been covering mPOC on a regular basis since 2013. Our latest report, The Market and Future Potential for Molecular Point-of-Care (mPOC),...Published: February 7, 2023 | Price: $5,000.00 – $10,000.00
This report is an essential tool for understanding the size and growth opportunity in molecular POC. Molecular point of care (mPOC) has gone from novel trend to significant contributor to the market. The instruments sold by Abbott, BioMérieux, Cepheid and increasingly, a host of other companies, are a significant contributor to the IVD POC market. Knowing these markets is essential to knowing the opportunity in point of care testing and microbiology IVD. Since 2013, Kalorama has been producing a dedicated...Published: October 26, 2020 | Price: $3,000.00 – $6,000.00
The diagnosis and treatment of sepsis is one of the biggest challenges facing healthcare currently. In the United States, there are around 1.7 million cases of sepsis per year, resulting in approximately 270,000 deaths. Overall, the costs associated with sepsis make it the most expensive condition treated in US hospitals. This report provides comprehensive information on products in the sepsis market, as well as: Sepsis Detection Practice Trends Sepsis Related Biomarkers: Advantages and Disadvantages Markets for Sepsis-Related Testing Mass...Published: November 27, 2023 | Price: $5,000.00 – $10,000.00
Telehealth and remote patient monitoring have become integral to improving health conditions and preventing health complications. The transformations observed during the pandemic have bolstered telemedicine and, consequently, remote patient monitoring, instilling confidence in virtual patient assessment and access to advanced technological monitoring. Since January 2019, remote patient monitoring has experienced a significant surge, and current telehealth systems are leveraging key technologies increasingly prevalent in the health industry to foster further growth. Kalorama Information analyzes these trends and more in Remote...Published: April 24, 2024 | Price: $10,500.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests report, World Market for Molecular Diagnostics report or Molecular Point-of-Care (mPOC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel spreadsheet...Published: May 5, 2022 | Price: $10,000.00
NOTE: The Kalorama Molecular Diagnostics Quarterly Datastream is only available to those who have purchased our Worldwide In Vitro Diagnostic Tests Report, World Molecular Diagnostics Report or Molecular Point-of-Care (POC) report. All in any edition. This is because this is a quarterly update to markets covered in these reports. The most up-to-date information for company-wide success. Buyers will receive data updates after each financial quarter for one year (for a total of four updates). These comprehensive updates come in an Excel...Published: April 12, 2021 | Price: $4,000.00 – $8,000.00
Contract manufacturing is an increasing part of the pharmaceutical business. In cell therapy this need is magnified because of the demand for cell and gene therapy products. Kalorama Information's report the Market for Cell and Gene Therapy Contract Manufacturing Organizations (CMOs) details the following: Biopharmaceutical Contract Manufacturing Market Role Services Offered Usage Drivers Profiles of Companies, Key Players, and Competitors in the Market COVID-19’s Challenges and Opportunities for CMOs Global and Regional Market Overviews—U.S., Europe, and Other Nations New Developments and...Published: April 7, 2020 | Price: $750.00 – $1,000.00
For years, Kalorama Information has covered the fields of molecular diagnostics, immunoassays, vaccines and telehealth. These all find themselves both sought-after and challenged during the current COVID-19 crisis. This report provides trending developments, company announcements and analysis from the Kalorama analysis team on the fast-breaking events in the COVID-19 epidemic. Particular sections address the most important market changes: Molecular Diagnostics: It's important to note that the entire molecular testing concept originated in the midst of a crisis, at that time...Published: May 14, 2020 | Price: $4,000.00 – $8,000.00
CLICK HERE TO VIEW NEW VERSION OF THIS REPORT The current COVID-19 crisis affecting the United States and the world has caused hundreds of thousands of deaths and countless economic costs. This has brought forth an array of solutions that could contribute to detecting, containing and possibly treating the disease. Kalorama Information has covered the fields of molecular diagnostics, vaccines and telehealth for decades. These important industries, already growing in revenues and number of competitors, now find themselves part of...Published: November 17, 2022 | Price: $5,000.00 – $10,000.00
What’s Driving Growth in the IVD Market in Q3 and the last half of 2022? What Major Trends are Affecting the Market in Q3 and the last half of 2022? How Has COVID-19 Impacted and Continued to Impact the Market in Q3 and the last half of 2022? What Product Trends and New Developments Will Shape the IVD Market in the last half of 2022? Diagnostic test products have never been more important. This report is an update of the...Published: March 23, 2022 | Price: $5,000.00 – $10,000.00
What’s Driving Growth in the IVD Market in 2022? What Major Trends are Affecting the Market in 2022? How Has COVID-19 Impacted and Continued to Impact the Market in 2022? What Product Trends and New Developments Will Shape the IVD Market in 2022? Diagnostic test products have never been more important. This report is an update of the market for in vitro diagnostics products from Kalorama’s analysts to reflect the latest information as of Q1 2022. The demand for testing...Published: March 17, 2023 | Price: $3,750.00 – $7,500.00
Diagnostic testing continues to be a valuable resource to help physicians arrive at a diagnosis. Additionally, it has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. Now, in the aftermath of the COVID-19 pandemic, new products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors that produce a constantly changing market picture but one that remains resilient. Ultimately, the...Published: April 7, 2022 | Price: $6,000.00 – $12,000.00
The Most Comprehensive and Reliable Market Sizing and Forecasts in Infectious Disease IVD [caption id="attachment_18836" align="aligncenter" width="300"] Attend a WEBINAR on this topic.[/caption] Infectious disease testing comprises one of the largest and fastest growing applications served by the global in vitro diagnostics (IVD) industry. Infectious diseases are ailments caused by pathogenic microorganisms that invade the body, either directly or indirectly via afflicted carriers or contaminated sources. IVD tests for these conditions are designed to detect and identify the...Published: September 29, 2021 | Price: $4,000.00 – $8,000.00
As an in vitro diagnostics (IVD) market, China trails only the populous, developed economy markets of the United States, western European countries, and Japan. The country and its healthcare system are confronted by challenges shared by less developed countries, but also burdens common among developed middle-income and affluent countries such as diabetes, cardiovascular disease, and diseases of aging. China as an IVD market opportunity is defined by its standing next to other populous countries with demonstrated economic promise for over...Published: October 18, 2022 | Price: $5,000.00 – $10,000.00
The Asia Pacific (APAC) region is a fast-growing in vitro diagnostics (IVD) market, which is witnessing increasing focus by leading global players in the market. Southeast Asia has been identified as one of the key regions in APAC region offering significant opportunities for IVD companies. This report focuses on three IVD markets in Southeast Asia: Malaysia, Indonesia, and Singapore. These three countries together represent a fast-growing geographic region offering significant opportunity for IVD companies. The total population of these three...Published: November 7, 2023 | Price: $3,750.00 – $7,500.00
In vitro diagnostic (IVD) testing is getting back to regular business and continues to be a driving force in the practice of medicine. It has gone from helping the physician to diagnose illness to providing the physician with invaluable information on treatments such as precision medicine. COVID-19 testing continues to decline but is still a factor in total revenues for 2023. New products, changes in global health spending, regulatory changes in major markets and disease trends are among the factors...Published: March 27, 2024 | Price: $5,000.00 – $10,500.00
Diagnostic testing has become a fundamental aspect of healthcare, aiding physicians in diagnosing conditions and determining treatments. Despite a decline in COVID-19 testing affecting total revenues, core diagnostic segments have generally experienced growth. Factors such as new products, changes in global health spending, regulatory shifts, and disease trends contribute to a constantly changing market, yet one that remains resilient. Key growing segments attracting industry attention include next-generation sequencing (NGS), personalized medicine, and mass spectrometry. Immunochemistry, point-of-care (POC) testing, and molecular...Published: September 22, 2023 | Price: $6,000.00 – $12,000.00
In vitro diagnostic (IVD) test volumes are the gold standard for sizing the market opportunity for new entrants with diagnostic products, and they can be useful for existing product marketers. The market analysis in Kalorama Information’s In Vitro Diagnostic (IVD) Procedure Volumes (Chemistry, Immunoassays, Hematology, Microbiology, Histology, Point of Care), 2023-2028 saves time with calculations and estimates of both the existing number of procedures for scores of diagnostic tests and the future potential. In the process, pricing analysis is also performed. This report...